Volume 8, Issue 4, Pages (April 2011)

Slides:

Advertisements

Similar presentations

ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW

Advertisements

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Treatment Times Through Formalized.

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:

Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Crushed Prasugrel Tablets in Patients With STEMI.

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:

Volume 8, Issue 5, Pages (May 2011)

Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized.

Volume 11, Issue 2, Pages (February 2014)

Copyright © 2005 American Medical Association. All rights reserved.

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

The challenge of achieving 1% operative mortality for coronary artery bypass grafting: A multi-institution Society of Thoracic Surgeons Database analysis

Volume 11, Issue 8, Pages (August 2014)

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Volume 5, Issue 4, Pages (April 2008)

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Sudden Cardiac Death From the Perspective of Coronary Artery Disease

Volume 8, Issue 5, Pages (May 2011)

Postinfarction Ventricular Septal Defects: Towards a New Treatment Algorithm? Simon Maltais, MD, MS, Reda Ibrahim, MD, Arsène-Joseph Basmadjian, MD, Michel.

Fred H. Edwards, MD, David M. Shahian, MD, Maria V

Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Figure 1 PCI strategies in patients with STEMI and multivessel disease

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Efficacy and Safety of Thrombin-Receptor Antagonist (Atopaxar and Vorapaxar) in Patients with Acute Coronary Syndrome or Coronary Artery Disease—A Meta-Analysis.

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Volume 8, Issue 7, Pages (July 2011)

Volume 11, Issue 2, Pages (February 2014)

Volume 8, Issue 4, Pages (April 2011)

Role of adipose tissue in the pathogenesis of cardiac arrhythmias

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Volume 9, Issue 6, Pages (June 2012)

Ethnic and racial disparities in cardiac resynchronization therapy

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

National Trends in the Incidence, Management, and Outcomes of Heart Failure Complications in Patients Hospitalized for ST-Segment Elevation Myocardial.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Volume 7, Issue 7, Pages (July 2010)

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.

Microplegia During Coronary Artery Bypass Grafting Was Associated With Less Low Cardiac Output Syndrome: A Propensity-Matched Comparison Khaled D. Algarni,

For everything there is a season

Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock

Volume 15, Issue 1, Pages (January 2018)

Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease Noam Fink, MD, Eugenia Nikolsky, MD, Abid Assali, MD,

Volume 8, Issue 3, Pages (March 2011)

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Ticagrelor versus prasugrel; risk ratio with 95% CIs for the primary composite end point, primary composite end point in those undergoing PCI, myocardial.

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Figure 7. Subgroup analysis according to the study design and support of CPB during CABG. The study design and support of CPB did not affect the results.

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: A randomized trial Vito A. Mannacio, MD, Domenico Iorio, MD, Vincenzo.

Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.

Presentation transcript:

Volume 8, Issue 4, Pages 493-499 (April 2011) Effect of reperfusion time on inducible ventricular tachycardia early and spontaneous ventricular arrhythmias late after ST elevation myocardial infarction treated with primary percutaneous coronary intervention Saurabh Kumar, BSc(Med)/MBBS, Gopal Sivagangabalan, MBBS, Aravinda Thiagalingam, MBChB, PhD, Elizabeth B. West, MBBS, Arun Narayan, RN, Norman Sadick, MBBS, PhD, Andrew T.L. Ong, MBBS, PhD, Pramesh Kovoor, MBBS, PhD Heart Rhythm Volume 8, Issue 4, Pages 493-499 (April 2011) DOI: 10.1016/j.hrthm.2010.11.046 Copyright © 2011 Terms and Conditions

Figure 1 Patient selection. CABG = coronary artery bypass graft; CAD = coronary artery disease; EF = ejection fraction; EPS = electrophysiologic study; ICD = implantable cardioverter-defibrillator; MI = myocardial infarction; PCI = primary percutaneous coronary intervention; STEMI = ST elevation myocardial infarction; TIMI = Thrombolysis in Myocardial Infarction. Heart Rhythm 2011 8, 493-499DOI: (10.1016/j.hrthm.2010.11.046) Copyright © 2011 Terms and Conditions

Figure 2 Reperfusion time and inducible ventricular tachycardia (VT). CI = confidence interval; OR = odds ratio. Heart Rhythm 2011 8, 493-499DOI: (10.1016/j.hrthm.2010.11.046) Copyright © 2011 Terms and Conditions

Figure 3 Reperfusion time and ease of inducibility by number of extrastimuli (ES). Heart Rhythm 2011 8, 493-499DOI: (10.1016/j.hrthm.2010.11.046) Copyright © 2011 Terms and Conditions